![]() Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | ![]() Prolong Pharmaceuticals Prolong Pharmaceuticals is a company providing SANGUINATE, a medication focusing on treating sickle cell disease and other disorders caused by anemia, hypoxia, or ischemia. | ||
Founding Date | Founding Date 1781 | Founding Date 1994 | Founding Date 2005 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Alameda, US HQ | Locations South Plainfield, US HQ | |
Employees | Employees 47,4554% decrease | Employees 1,14712% decrease | Employees 225% increase |
Valuation ($) | Valuation ($) 43.7 b | Valuation ($) 8.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥818.8b (FY, 2025) | Cost of goods $83.7m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥3.8t (FY, 2025) | Gross profit $2.2b (FY, 2025) | Gross profit N/A |
Net income | Net income ¥108.1b (FY, 2025) | Net income $782.6m (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 57.8m | Total funding raised N/A | Total funding raised $ 30m |

Exelixis is an oncology company that develops cancer treatments.
View company
Prolong Pharmaceuticals is a company providing SANGUINATE, a medication focusing on treating sickle cell disease and other disorders caused by anemia, hypoxia, or ischemia.
View company